@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix dct: .
@prefix pav: .
@prefix rdf: .
@prefix npx: .
@prefix xsd: .
@prefix rdfs: .
@prefix biolink: .
@prefix prov: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
a biolink:ChemicalEntity;
rdfs:label "milnacipran" .
a biolink:DiseaseOrPhenotypicFeature;
rdfs:label "Fibromyalgia" .
sub:_1 a rdf:Statement;
rdf:object ;
rdf:predicate biolink:treats;
rdf:subject .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2022-06-24T12:01:11+00:00"^^xsd:integer;
prov:hadPrimarySource ;
prov:wasAttributedTo orcid:0000-0002-1501-1082;
prov:wasQuotedFrom "Milnacipran HCl tablets are indicated for the management of fibromyalgia." .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB";
npx:hasSignature "CDUyd/M5aMIqRxTdagWPoSdi+Kg3Pgpd1sV1aLdlxFbbGHtyQ3IJomlPFd4oJHvjiMOXqPlXzTNpoK/pQio2zX9cHFalR50LbHDjQG6bZ8Wp2s+/3BFrGEfiG3u6ywTplK6WOzUX2KwNB1PtWzN0h7/LhqaWSpCrf5HODdazhpI=";
npx:hasSignatureTarget this: .
this: a npx:ExampleNanopub;
dct:created "2022-06-24T12:01:11+00:00"^^xsd:integer;
pav:createdBy orcid:0000-0002-1501-1082 .
}